OBJECTIVE: To describe the clinical course of affected and unaffected eyes in @entity1 with @entity937 . @entity1 : Prospective study of @entity1 with macular holes enrolled in the @entity2194 Case-Control Study. MAIN OUTCOME MEASURES: The best-corrected visual acuity at follow-up was compared with that at baseline. Changes in the macular holes, including increases in size or spontaneous regression, were assessed. The rates of development of new macular holes in fellow unaffected eyes were estimated. RESULTS: Of the 198 @entity1 examined at baseline, 28 (14.1%) died before reevaluation. Of those who survived, 122 (71.8%) had a follow-up examination. Approximately 34% (34.4%) of all eyes with macular holes had an increase in the size of the macular hole. Forty-five percent of eyes had a decrease in visual acuity of 2 or more lines and 27.8%, of 3 or more lines; 40.9% remained stable, with a gain or loss of fewer than 2 lines. The rate of development of a new macular hole during follow-up in fellow eyes that were unaffected at baseline was 4.3% for 3 or fewer years of follow-up, 6.5% for 4 to 5 years of follow-up, and 7.1% for 6 or more years of follow-up. Spontaneous regression of the macular hole occurred in 3 (8.6%) of 35 @entity1 with a follow-up interval of 6 or more years, whereas no regression occurred in @entity1 with a shorter follow-up. CONCLUSIONS: The visual acuity of 45.0% of eyes with macular holes deteriorated by 2 or more lines during follow-up. The rate of development of macular holes in unaffected fellow eyes was low.

Clinical course of macular holes: the XXXX Case-Control Study.

@entity1 :: ('9606', 'Species') :: ['PATIENTS', 'patients'] @entity2194 :: ('MESH:D005128', 'Disease') :: ['Eye Disease'] @entity937 :: ('MESH:D012167', 'Disease') :: ['idiopathic macular holes']
@entity2194 :: (MESH:D005128,Disease) :: ['Eye Disease']
